Astellas and Vir in $1.3B deal for CD3 T-cell engager
Astellas and Vir in $1.3B deal for CD3 T-cell engager
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.
Astellas and Vir in $1.3B deal for CD3 T-cell engager
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.